FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to drugs for treating arthrological diseases. Disclosed agent for treating arthrological diseases includes an effective amount of sodium chondroitin sulphate and at least one excipient or carrier, wherein the agent additionally contains iron in a relative amount of 1 mg/kg to 40 mg/kg in terms of the weight of sodium chondroitin sulphate.
EFFECT: high efficacy of the agent, high regeneration and accelerated growth of cartilage tissue and increased thickness of the cartilage; introduction of the above specified amount of iron into the compositions containing sodium chondroitin sulphate leads to reduction of the therapeutic course, increase of the cartilage tissue regeneration rate and reduction of side effects.
15 cl, 6 dwg, 10 tbl, 6 ex
